MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, XLO made $43,766K in revenue. -$35,036K in net income. Net profit margin of -80.05%.

Income Overview

Revenue
$43,766K
Net Income
-$35,036K
Net Profit Margin
-80.05%
EPS
-$4.19
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Total revenue
43,766
Research and development
56,039
General and administrative
29,709
Total operating expenses
85,748
Loss from operations
-41,982
Change in fair value of common stock warrant liabilities
-5,845
Other income, net
1,101
Total other income, net
6,946
Net loss and comprehensive loss
-35,036
Basic EPS
-4.19
Diluted EPS
-4.19
Basic Average Shares
8,359,109
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Change in fair value ofcommon stock warrant...-$5,845K Other income, net$1,101K Net loss andcomprehensive loss-$35,036K Total other income,net$6,946K Loss from operations-$41,982K Total revenue$43,766K Total operatingexpenses$85,748K Research and development$56,039K General andadministrative$29,709K

Xilio Therapeutics, Inc. (XLO)

Xilio Therapeutics, Inc. (XLO)